{"name":"MP Healthcare Venture Management","permalink":"mp-healthcare-venture-management-inc","crunchbase_url":"http://www.crunchbase.com/financial-organization/mp-healthcare-venture-management-inc","homepage_url":"http://www.mp-healthcare.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-737-4690","description":"","email_address":"MPH-WEB@mp-healthcare.com","number_of_employees":null,"founded_year":2006,"founded_month":null,"founded_day":null,"tag_list":"invests, biotechnology, biopharmaceutcals, therapeutics, diagnostics","alias_list":"","created_at":"Thu Jun 25 12:40:05 UTC 2009","updated_at":"Thu Jun 25 17:00:27 UTC 2009","overview":"<p>MPH is a venture capital firm that invest in innovative research and development that focuses in biotechnology, biopharmaceuticals, therapeutics and diagnostics.</p>","image":{"available_sizes":[[[150,17],"assets/images/resized/0005/0688/50688v2-max-150x150.png"],[[250,28],"assets/images/resized/0005/0688/50688v2-max-250x250.png"],[[397,46],"assets/images/resized/0005/0688/50688v2-max-450x450.png"]],"attribution":null},"offices":[{"description":"Headquarters","address1":"33 Arch Street, Suite 2202","address2":"","zip_code":"02110","city":"Boston","state_code":"MA","country_code":"USA","latitude":42.356157,"longitude":-71.058224}],"relationships":[{"is_past":false,"title":"President","person":{"first_name":"Junichi","last_name":"Watanabe","permalink":"junichi-watanabe","image":null}}],"investments":[{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/press-releases/intradigm-corporation-closes-final-tranche-21-4-million-series-b-financing-philip-haw","source_description":"Intradigm Corporation Closes Final Tranche of $21.4 Million Series B Financing; Philip Haworth, Ph.D. Appointed Chief Executive","raised_amount":21400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":7,"company":{"name":"Intradigm Corporation","permalink":"intradigm-corporation","image":{"available_sizes":[[[150,34],"assets/images/resized/0005/0666/50666v1-max-150x150.png"],[[250,56],"assets/images/resized/0005/0666/50666v1-max-250x250.png"],[[316,72],"assets/images/resized/0005/0666/50666v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pronota.com/?top=news&sub=press-releases&date=30102009","source_description":"Pronota","raised_amount":1950000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":30,"company":{"name":"Pronota","permalink":"pronota","image":{"available_sizes":[[[140,90],"assets/images/resized/0006/7923/67923v1-max-150x150.jpg"],[[140,90],"assets/images/resized/0006/7923/67923v1-max-250x250.jpg"],[[140,90],"assets/images/resized/0006/7923/67923v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"seed","source_url":"http://www.covagen.com/index.php?id=85","source_description":"Covagen","raised_amount":null,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":5,"company":{"name":"Covagen","permalink":"covagen","image":{"available_sizes":[[[150,28],"assets/images/resized/0006/8168/68168v1-max-150x150.jpg"],[[250,48],"assets/images/resized/0006/8168/68168v1-max-250x250.jpg"],[[311,60],"assets/images/resized/0006/8168/68168v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.f-star.com/press_releases/f-star_press_release_060110.pdf","source_description":"f-star raises â‚¬8m in an Extended Series A Financing co-led by MP Health-care Venture Management and Merck Serono Ventures","raised_amount":8000000,"raised_currency_code":"EUR","funded_year":2010,"funded_month":1,"funded_day":6,"company":{"name":"f-star Biotech","permalink":"f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","image":{"available_sizes":[[[148,150],"assets/images/resized/0007/2453/72453v1-max-150x150.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-250x250.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss","source_description":"FerroKin rounds up $12M for iron overload treatment  Read more: FerroKin rounds up $12M for iron overload treatment - FierceBiotech http://www.fiercebiotech.com/story/ferrokin-rounds-12m-iron-overload-treatment/2010-06-18?utm_medium=rss&utm_source=rss#ixz","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":6,"funded_day":18,"company":{"name":"FerroKin Biosciences","permalink":"ferrokin-biosciences","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.covagen.com/index.php?id=92","source_description":"Covagen closes Series A financing round with Seroba Kernel as lead investor","raised_amount":6300000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":29,"company":{"name":"Covagen","permalink":"covagen","image":{"available_sizes":[[[150,28],"assets/images/resized/0006/8168/68168v1-max-150x150.jpg"],[[250,48],"assets/images/resized/0006/8168/68168v1-max-250x250.jpg"],[[311,60],"assets/images/resized/0006/8168/68168v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/01/genocea-biosciences-closes-35m-series-b.html","source_description":"Genocea Biosciences Closes $35M Series B Financing Round","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":3,"company":{"name":"Genocea Biosciences","permalink":"genocea-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0009/8416/98416v1-max-150x150.png"],[[250,106],"assets/images/resized/0009/8416/98416v1-max-250x250.png"],[[256,109],"assets/images/resized/0009/8416/98416v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.reuters.com/article/2011/05/24/idUS48702+24-May-2011+HUG20110524","source_description":"GenKyoTex raises CHF 18 million in a Series C Venture Financing to develop NOX enzyme inhibitors","raised_amount":20400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":24,"company":{"name":"GenKyoTex","permalink":"genkyotex","image":{"available_sizes":[[[150,62],"assets/images/resized/0004/7604/47604v1-max-150x150.jpg"],[[189,79],"assets/images/resized/0004/7604/47604v1-max-250x250.jpg"],[[189,79],"assets/images/resized/0004/7604/47604v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.f-star.com/fstarPressRelease_3.pdf","source_description":"f-star raises â‚¬15M in a New Financing led by SR One","raised_amount":15000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":4,"funded_day":13,"company":{"name":"f-star Biotech","permalink":"f-star-biotechnologische-forschungs-und-entwicklungsges-m-b-h","image":{"available_sizes":[[[148,150],"assets/images/resized/0007/2453/72453v1-max-150x150.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-250x250.jpg"],[[148,150],"assets/images/resized/0007/2453/72453v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://finance.yahoo.com/news/genkyotex-raises-chf25-million-series-070000381.html","source_description":"Genkyotex Raises CHF25 Million in Series C Round Extension","raised_amount":26000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":9,"company":{"name":"GenKyoTex","permalink":"genkyotex","image":{"available_sizes":[[[150,62],"assets/images/resized/0004/7604/47604v1-max-150x150.jpg"],[[189,79],"assets/images/resized/0004/7604/47604v1-max-250x250.jpg"],[[189,79],"assets/images/resized/0004/7604/47604v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.masshightech.com/stories/2012/10/08/daily28-Genocea-raises-30M-to-advance-herpes-vaccine.html","source_description":"Genocea raises $30M to advance herpes vaccine","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":10,"company":{"name":"Genocea Biosciences","permalink":"genocea-biosciences","image":{"available_sizes":[[[150,63],"assets/images/resized/0009/8416/98416v1-max-150x150.png"],[[250,106],"assets/images/resized/0009/8416/98416v1-max-250x250.png"],[[256,109],"assets/images/resized/0009/8416/98416v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.businesswire.com/news/edmontonjournal/20121025005392/en/Thrasos-Secures-35-Million-Fund-THR-184-Phase","source_description":"Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":25,"company":{"name":"Thrasos","permalink":"thrasos","image":{"available_sizes":[[[150,56],"assets/images/resized/0021/7327/217327v1-max-150x150.jpg"],[[250,94],"assets/images/resized/0021/7327/217327v1-max-250x250.jpg"],[[252,95],"assets/images/resized/0021/7327/217327v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}